Earnings summaries and quarterly performance for AMETEK INC/.
Executive leadership at AMETEK INC/.
David A. Zapico
Detailed
Chairman and Chief Executive Officer
CEO
DP
Dalip Puri
Detailed
Executive Vice President–Chief Financial Officer
DH
David Hermance
Detailed
President–Electromechanical Group
ES
Emanuela Speranza
Detailed
Chief Commercial Officer
JH
John Hardin
Detailed
President–Electronic Instruments
RA
Robert Amodei
Detailed
Senior Vice President, Controller and Principal Accounting Officer (effective January 1, 2026)
RO
Ronald Oscher
Detailed
Chief Administrative Officer
TM
Thomas Marecic
Detailed
President–Electronic Instruments
TM
Thomas Montgomery
Detailed
Senior Vice President–Comptroller & Principal Accounting Officer
TC
Tony Ciampitti
Detailed
President–Electronic Instruments
Board of directors at AMETEK INC/.
Research analysts who have asked questions during AMETEK INC/ earnings calls.
AO
Andrew Obin
Bank of America
6 questions for AME
Also covers: ALH, ALLE, CARR +17 more
Scott Graham
Seaport Research Partners
5 questions for AME
Also covers: AEIS, AOS, APH +8 more
BL
Brett Linzey
Mizuho Securities
4 questions for AME
Also covers: AIRO, AIT, ALLE +15 more
Deane Dray
RBC Capital Markets
4 questions for AME
Also covers: ATKR, CARR, DOV +20 more
JS
Jeffrey Sprague
Vertical Research Partners
4 questions for AME
Also covers: ALLE, AYI, CARR +23 more
MS
Matt Summerville
D.A. Davidson & Co.
4 questions for AME
Also covers: ALTG, AOS, B +17 more
NC
Nigel Coe
Wolfe Research, LLC
4 questions for AME
Also covers: CARR, CNM, DOV +28 more
Robert Wertheimer
Melius Research
4 questions for AME
Also covers: ALSN, CAT, CMI +12 more
AB
Andrew Buscaglia
BNP Paribas
3 questions for AME
Also covers: APH, CGNX, EMR +11 more
Christopher Glynn
Oppenheimer & Co. Inc.
3 questions for AME
Also covers: AIT, AYI, B +16 more
Christopher Snyder
Morgan Stanley
3 questions for AME
Also covers: ALH, ALLE, AYI +20 more
Jamie Cook
Truist Securities
3 questions for AME
Also covers: ACM, AGCO, CAT +17 more
JG
Joseph Giordano
TD Cowen
3 questions for AME
Also covers: ABLZF, APH, ASAI +21 more
JM
Julian Mitchell
Barclays Investment Bank
2 questions for AME
Also covers: AIRJ, ALLE, APG +26 more
MS
Matthew Summerville
D.A. Davidson
2 questions for AME
MA
Michael Anastasiou
Cowen and Company
2 questions for AME
Also covers: CGNX, ITT
Robert Jamieson
Vertical Research Partners
2 questions for AME
Also covers: BDC, KEYS, NDSN +4 more
Deane Michael Dray
RBC Capital Markets
1 question for AME
JM
Jacob Moore
Sidoti & Company, LLC
1 question for AME
Also covers: FLEX, FSS, KMT +3 more
NE
Nigel Edward Coe
Wolfe Research
1 question for AME
RM
Robert Mason
Robert W. Baird & Co.
1 question for AME
Also covers: AEIS, ATMU, BMI +12 more
Rob Wertheimer
Melius Research LLC
1 question for AME
Also covers: ALSN, CAT, CMI +11 more
SG
Sahil Guttal
RBC Capital Markets
1 question for AME
SB
Steve Barger
KeyBanc Capital Markets Inc.
1 question for AME
Also covers: AEIS, AMKR, FLEX +12 more
Recent press releases and 8-K filings for AME.
AMETEK reports record Q4 and FY 2025 results
AME
Earnings
- AMETEK’s Q4 2025 sales reached $2.0 billion, up 13% year-over-year; GAAP EPS was $1.73, while adjusted EPS rose 7% to $2.01.
- Q4 operating income hit a record $505.5 million (adjusted $523.0 million), with operating cash flow of $584.3 million and free cash flow of $527.3 million.
- For FY 2025, sales were $7.4 billion, up 7%; GAAP EPS was $6.40, and adjusted EPS grew 9% to $7.43, with adjusted operating margin of 26.2%.
6 hours ago
AMETEK reports Q4 and full-year 2025 results
AME
Earnings
Guidance Update
M&A
- Record Q4 sales of $2.0 billion (+13% YoY) and operating income of $523 million (+12%) with core margin up 100 bps to 27.6%
- Full-year 2025 sales of $7.4 billion (+7%), operating income $1.94 billion (+7%), and EPS of $7.43 (+9%)
- Free cash flow of $527 million in Q4 (up 6%) with 132% conversion of net income; $443 million in share repurchases for the year
- Completed acquisitions of FARO Technologies and Kern Microtechnik (~$1 billion), added LKC Technologies in Q4; capacity to deploy $5 billion while maintaining investment-grade rating
- 2026 outlook: sales up mid- to high-single digits (organic low- to mid-single digits); EPS guidance $7.87–$8.07 (+6–9%)
8 hours ago
AMETEK reports Q4 and full-year 2025 results
AME
Earnings
Guidance Update
M&A
- AMETEK delivered record $2.0 billion Q4 sales (+13%), $2.0 billion Q4 orders (+18%), operating income of $523 million (+12%) and EPS of $2.01 (+7%) versus prior year.
- FY 2025 sales reached $7.4 billion (+7%), operating income $1.94 billion (+7%), EBITDA $2.33 billion (+7%) and diluted EPS $7.43 (+9%).
- Q4 organic sales grew 5%, acquisitions added 7 points, FX contributed +1 point; backlog ended at a record $3.58 billion.
- Completed acquisitions of FARO Technologies and Kern Microtechnik (~$1 billion), and announced LKC Technologies deal to broaden med-tech offerings.
- 2026 outlook: sales up mid- to high-single digits (organic +low- to mid-single digits), EPS $7.87–$8.07; Q1 sales +~10% with EPS of $1.90–$1.95.
10 hours ago
AMETEK reports Q4 2025 earnings
AME
Earnings
Guidance Update
M&A
- AMETEK delivered record Q4 sales of $2.0 billion (up 13% YoY; organic +5%, acquisitions +7%, FX +1) and orders of $2.0 billion (up 18% YoY; organic +7%), driving a backlog of $3.58 billion.
- Q4 operating income was $523 million (up 12% YoY) with core operating margins of 27.6% (up 100 bps); EBITDA reached $618 million (up 10%; margin 30.9%).
- Free cash flow in the quarter was $527 million (up 6% YoY) with a 132% free cash flow to net income conversion; full-year free cash flow was $1.7 billion (113% conversion).
- For 2026, AMETEK guides sales growth of mid- to high-single digits (organic up low- to mid-single digits) and EPS of $7.87–$8.07 (up 6–9%); Q1 sales are expected +10% with EPS of $1.90–$1.95 (up 6–9%).
- Completed the acquisitions of LKC Technologies to expand med-tech exposure and FARO Technologies, deploying over $1.8 billion on acquisitions and returning $443 million in share repurchases in 2025.
10 hours ago
AMETEK reports record Q4 and full-year 2025 results
AME
Earnings
Guidance Update
- Record Q4 results: sales of $2.0 billion (+13% y/y), GAAP EPS $1.73, adjusted EPS $2.01
- Full-year 2025 performance: sales of $7.4 billion (+7% y/y), GAAP EPS $6.40, adjusted EPS $7.43, operating income $1.91 billion
- Segment performance: Q4 EIG sales $1.37 billion (+13%) with operating income $396.1 million; EMG sales $628.9 million (+15%) with operating income $142.5 million
- Cash flow strength: Q4 operating cash flow $584.3 million, free cash flow $527.3 million, free cash flow to net income conversion 132%
- 2026 guidance: expects mid- to high-single-digit sales growth, adjusted EPS $7.87–$8.07, and Q1 sales growth ~10% with adjusted EPS $1.85–$1.90
13 hours ago
AMETEK announces record Q3 2025 results
AME
Earnings
Guidance Update
- AMETEK reported record Q3 sales of $1.89 billion, up 11% YoY, with GAAP EPS of $1.60 and adjusted EPS of $1.89, a 14% increase YoY.
- Q3 GAAP operating income was $488.4 million (25.8% margin), while adjusted operating income reached $496.1 million, up 11% year-over-year.
- Electronic Instruments Group sales grew 10% to $1.25 billion (adjusted operating income $360.2 million, +6%), and Electromechanical Group sales rose 13% to $646.3 million (operating income $163.9 million, +25%).
- AMETEK raised its 2025 adjusted EPS guidance to $7.32–$7.37, up 7–8% over 2024, and expects Q4 sales growth of ~10% with adjusted EPS of $1.90–$1.95.
Oct 30, 2025, 2:59 PM
AMETEK announces Q3 2025 results
AME
Earnings
Guidance Update
M&A
- Record Q3 sales of $1.89 billion (up 11% Y/Y; organic +4%), orders of $1.97 billion (up 13%; organic +7%) and backlog of $3.54 billion
- Operating income of $496 million (+11% Y/Y), EBITDA of $592 million (+11%) and diluted EPS of $1.89 (+14%); raised full-year EPS guidance to $7.32–$7.37 (prior $7.06–$7.20)
- Segment performance: EIG sales of $1.25 billion (+10%; margin ex-acquisitions 30.4%, +50 bps) and EMG sales of $646 million (+13%; margin 25.4%, +250 bps)
- Strong cash flow: Q3 free cash flow of $420 million (113% conversion), net debt/EBITDA at 0.9×; deployed $920 million on FARO acquisition, $150 million on buybacks, and $71 million in dividends
Oct 30, 2025, 12:30 PM
AMETEK reports Q3 2025 results
AME
Earnings
Guidance Update
M&A
- Recorded Q3 sales of $1.89 billion, up 11%, with operating income of $496 million (+11%) and diluted EPS of $1.89 (+14%).
- Raised full-year diluted EPS guidance to $7.32–$7.37, and expects Q4 sales up ~10% with EPS of $1.90–$1.95.
- Generated $441 million in operating cash flow and $420 million in free cash flow (113% conversion); ended Q3 with net debt/EBITDA of 0.9× and deployed $920 million on FARO, $150 million on buybacks, and $71 million in dividends.
- Achieved record segment results: Electronic Instruments Group sales of $1.25 billion (+10%), with 30.4% operating margin ex-acquisitions; Electromechanical Group sales of $646 million (+13%) with 25.4% margin ex-acquisitions.
- Recent acquisitions (FARO, Vertech, Kern, Paragon) are integrating well, and the M&A pipeline remains robust for further strategic deals.
Oct 30, 2025, 12:30 PM
AMETEK reports Q3 2025 results
AME
Earnings
Guidance Update
- AMETEK delivered record third-quarter sales of $1.89 billion (up 11% y/y), with organic sales +4% and orders of $1.97 billion (up 13%).
- Operating performance was strong: operating income of $496 million (up 11%), EBITDA of $592 million (+11%), and diluted EPS of $1.89 (up 14%).
- Raised full-year EPS guidance to $7.32–$7.37 (up 7–8% vs. 2024); Q4 outlook calls for ~10% sales growth and EPS of $1.90–$1.95.
- Generated $420 million of free cash flow in Q3 (113% conversion) and maintained a net debt/EBITDA ratio of 0.9×.
Oct 30, 2025, 12:30 PM
AMETEK announces record Q3 2025 results and raises full-year guidance
AME
Earnings
Guidance Update
- Record Q3 sales of $1.89 billion (up 11% YoY); GAAP EPS of $1.60 and adjusted EPS of $1.89 (up 14% YoY).
- GAAP operating income of $488.4 million (25.8% margin) and adjusted operating income of $496.1 million (up 11% YoY).
- EIG sales of $1.25 billion (up 10% YoY) and EMG sales of $646.3 million (up 13% YoY), with margin expansion of 50 bps and 250 bps, respectively.
- Raised full-year adjusted EPS guidance to $7.32–$7.37 (up 7–8% YoY) and expects Q4 sales up ~10% with adjusted EPS of $1.90–$1.95.
Oct 30, 2025, 10:55 AM
Quarterly earnings call transcripts for AMETEK INC/.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more